News and Newsworthiness

As a university public relations professional, I was interested in Susan Fitzpatrick's Opinion article, "What Makes Science News Newsworthy?"1 I disagree, however, with her conclusion that scientists (and, by implication, PR people) should be more discriminating in which studies they pitch to the media. University PR people are generally very aware of what the media needs and wants in terms of news. More often than not we gently advise faculty that their studies may not be appropriate for

Written byJanice Zazinski
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

As a university public relations professional, I was interested in Susan Fitzpatrick's Opinion article, "What Makes Science News Newsworthy?"1 I disagree, however, with her conclusion that scientists (and, by implication, PR people) should be more discriminating in which studies they pitch to the media.

University PR people are generally very aware of what the media needs and wants in terms of news. More often than not we gently advise faculty that their studies may not be appropriate for the general public.

Any PR person would find it hard to believe, as Fitzpatrick implies, that the press publishes science stories because they're there. I for one have never been able to force a reporter to write a story against her will in my entire career. I would, however, suggest that the changing nature of the media business (emphasis on "business") drives most of the editorial decisions today.

Janice Zazinski

Public Relations ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies